Estimated log‐years of survival differences (and 95% confidence intervals) between hormonal therapy and no hormonal therapy among female breast cancer patients according to categories of body mass index (BMI) and hormone receptor status (HR). This evidence concerns the gene NR4A1 and breast carcinoma.